Related Experiment Video

Updated: Aug 16, 2025

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

2.2K

Sodium glucose co-transport 2 inhibitors for gout treatment

Manoj Kumar Reddy Somagutta1,2, Enkhmaa Luvsannyam2, Molly Jain3

  • 1Department of Family Medicine, Southern Illinois School of Medicine, Springfield, Illinois.

Discoveries (Craiova, Romania)
|December 21, 2022
PubMed

Insights

Sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) show promise in reducing gout risk and managing related complications. Further research is needed on their efficacy and safety in gout patients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Rheumatology

Background:

  • Hyperuricemia is the primary cause of gout, characterized by joint inflammation and uric acid crystal deposition.
  • Gout is linked to increased risks of insulin resistance, diabetes, metabolic disorders, cardiometabolic issues, and kidney disease.
  • Current gout treatments offer limited cardiovascular risk reduction, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To review the current knowledge on the role and effectiveness of novel antidiabetic medications in gout patients.
  • To explore the potential of Sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) as an early therapeutic option for gout.

Main Methods:

  • Literature review summarizing existing studies on SGLT2 inhibitors and their association with gout.
  • Analysis of SGLT2 inhibitors' effects on uric acid levels, weight loss, insulin resistance, and cardiovascular benefits.

Main Results:

  • SGLT2 inhibitors lower serum uric acid levels by inhibiting glucose reabsorption.
  • Emerging evidence suggests SGLT2 inhibitors may reduce gout risk in individuals with type 2 diabetes.
  • SGLT2 inhibitors offer potential benefits for gout complications, including weight loss and improved insulin resistance.

Conclusions:

  • SGLT2 inhibitors represent a potential novel therapeutic option for gout management, addressing associated metabolic and cardiovascular risks.
  • Further research is warranted to establish the safety and efficacy of SGLT2 inhibitors specifically in gout patients.

Keywords:
Cardiovascular healthDapagliflozin.GoutHyperuricemiaSodium-glucose transporter-2 inhibitors

More Related Videos

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.0K
Simple Continuous Glucose Monitoring in Freely Moving Mice03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

5.7K

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
234
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
122.4K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.9K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
211
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
258
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
832